Seventh Annual JADPRO Live Conference for Oncology Advanced Practitioners Explores Innovation in Cancer Care

Published by Annie Yueh 4 years ago

LAWRENCEVILLE, N.J. (PRWEB) May 03, 2019--Over 1,400 nurse practitioners, PAs, and pharmacists (collectively referred to as advanced practitioners, or APs) will gather together for the seventh annual JADPRO Live conference to discuss the latest improvements in cancer care and advance the integral role of APs on the collaborative care team. The meeting will take place from October 24 through 27 at the Washington State Convention Center in Seattle.

“We are very excited for JADPRO Live to come to Seattle,” said Gabrielle Zecha, PA-C, MHA, Director of Advanced Practice Providers at Seattle Cancer Care Alliance and Conference Chair for JADPRO Live 2019. “Medical innovation is key to better patient outcomes, and there is no place like Seattle to be a part of that innovation.”

Innovations in cancer care delivery have revolutionized the way clinicians care for patients with cancer. The accelerated pace of discovery offers exciting new options for patients with previously poor outcomes, but with it brings challenges to stay up to date on providing high-quality, effective care to patients.

Among the US practices that responded to the 2017 American Society of Clinical Oncology practice census, 81% reported employment of APs. The aging US population and projected shortage of hematologists/oncologists have propelled the roles and responsibilities of APs on oncology care teams in all types of practice settings.

JADPRO Live is the largest oncology conference for APs, inspired by the first journal written by and for oncology and hematology advanced practitioners, the Journal of the Advanced Practitioner in Oncology (JADPRO). It is held in conjunction with the Advanced Practitioner Society for Hematology and Oncology (APSHO) annual meeting, a society of more than 1,500 highly specialized clinicians who are on the frontlines of patient care, managing treatment plans, educating patients, and elevating the quality of care through interdisciplinary collaboration.

Over 4 days, more than 50 acclaimed speakers will showcase the latest in evidence-based care, and attendees can earn more than 20 continuing education credits at certified sessions. Activities to network and interact with other attendees will take place both within the session rooms and in the exhibit hall.

More information about the conference is available at

About JADPRO Live 

JADPRO Live is a medical conference inspired by the Journal of the Advanced Practitioner in Oncology. This year’s meeting will take place from October 24 through 27, at the Washington State Convention Center in Seattle. Learn more at

About APSHO 

The Advanced Practitioner Society for Hematology and Oncology (APSHO) is a society for advanced practitioners—nurse practitioners, physician assistants, pharmacists, clinical nurse specialists, and other oncology health-care professionals. The mission of APSHO is to promote oncology patient care that is high quality, cost effective, and delivered through collaborative practice models by optimizing the role of the advanced practitioner as an integral member of the care team. Learn more at

About Harborside 

Harborside is the foremost medical communications company that oncology clinicians turn to for accurate content, news, and education. The company is based in Huntington, New York, and is the publisher of the Journal of the Advanced Practitioner in Oncology (JADPRO), The ASCO Post, JNCCN—Journal of the National Comprehensive Cancer Network, and the Journal of Oncology Practice. Harborside designs educational resources for nurse practitioners, PAs, pharmacists, and other advanced practitioners by publishing JADPRO, organizing the JADPRO Live conferences, and providing the management services for the Advanced Practitioner Society for Hematology and Oncology. Harborside also manages the advertising sales for ASCO’s suite of publications, including the Journal of Clinical Oncology (JCO), the Journal of Global Oncology, JCO Clinical Cancer Informatics, and JCO Precision Oncology.